Simulations Plus Comprehensive Income 2010-2024 | SLP
Simulations Plus comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Simulations Plus Annual Comprehensive Income
(Millions of US $) |
| 2024 |
$-0 |
| 2023 |
$-0 |
| 2022 |
$-0 |
| 2021 |
$-0 |
| 2020 |
$0 |
| 2019 |
$ |
| 2018 |
$ |
| 2017 |
$ |
| 2016 |
$ |
| 2015 |
$ |
| 2014 |
$ |
| 2013 |
$ |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
Simulations Plus Quarterly Comprehensive Income
(Millions of US $) |
| 2024-08-31 |
$-0 |
| 2024-05-31 |
$-0 |
| 2024-02-29 |
$-0 |
| 2023-11-30 |
$-0 |
| 2023-08-31 |
$-0 |
| 2023-05-31 |
$-0 |
| 2023-02-28 |
$-0 |
| 2022-11-30 |
$-0 |
| 2022-08-31 |
$-0 |
| 2022-05-31 |
$-0 |
| 2022-02-28 |
$-0 |
| 2021-11-30 |
$-0 |
| 2021-08-31 |
$-0 |
| 2021-05-31 |
$0 |
| 2021-02-28 |
$0 |
| 2020-11-30 |
$0 |
| 2020-08-31 |
$0 |
| 2020-05-31 |
$0 |
| 2020-02-29 |
|
| 2019-11-30 |
|
| 2019-08-31 |
|
| 2019-05-31 |
|
| 2019-02-28 |
|
| 2018-11-30 |
|
| 2018-08-31 |
|
| 2018-05-31 |
|
| 2018-02-28 |
|
| 2017-11-30 |
|
| 2017-08-31 |
|
| 2017-05-31 |
|
| 2017-02-28 |
|
| 2016-11-30 |
|
| 2016-08-31 |
|
| 2016-05-31 |
|
| 2016-02-29 |
|
| 2015-11-30 |
|
| 2015-08-31 |
|
| 2015-05-31 |
|
| 2015-02-28 |
|
| 2014-11-30 |
|
| 2014-08-31 |
|
| 2014-05-31 |
|
| 2014-02-28 |
|
| 2013-11-30 |
|
| 2013-08-31 |
|
| 2013-05-31 |
|
| 2013-02-28 |
|
| 2012-11-30 |
|
| 2012-08-31 |
|
| 2012-05-31 |
|
| 2012-02-29 |
|
| 2011-11-30 |
|
| 2011-08-31 |
|
| 2011-05-31 |
|
| 2011-02-28 |
|
| 2010-11-30 |
|
| 2010-08-31 |
|
| 2010-05-31 |
|
| 2010-02-28 |
|
| 2009-11-30 |
|
| 2009-08-31 |
|
| 2009-05-31 |
|
| 2009-02-28 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.554B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
